TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

Pelthos Therapeutics Inc. (NYSE American: PTHS) announced the appointment of veteran finance executive Andrew J. Einhorn to its Board of Directors effective immediately. Einhorn brings over four decades of experience in investment banking, capital markets, and C-level finance roles at life science companies. He will serve on the Audit Committee and Compensation Committee. The appointment increases the Pelthos Board to eight directors.

Insights
LLY   positive

On pace for tenth gain in eleven sessions, stock price increased 1.89%


PTHS   positive

The appointment of an experienced finance executive with 40+ years in investment banking and capital markets, combined with 20 years of CFO experience at biotech companies, signals strengthened financial leadership and governance. This is expected to support the company's growth as a newly public, commercially-focused biopharmaceutical company with an FDA-approved product (ZELSUVMI).